Global Neurological Disorder Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
- MAI4658324
- 112 Pages
- October 2021
- BFSI
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Neurological Disorder Drugs market covered in Chapter 5:
Merck & Co.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Novartis AG
F. Hoffmann-La Roche Ltd.
AstraZeneca
Teva Pharmaceutical Industries Ltd.
Bayer AG
In Chapter 6, on the basis of types, the Neurological Disorder Drugs market from 2015 to 2025 is primarily split into:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
In Chapter 7, on the basis of applications, the Neurological Disorder Drugs market from 2015 to 2025 covers:
Hospital
Clinic
Home
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Neurological Disorder Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Merck & Co.
5.1.1 Merck & Co. Company Profile
5.1.2 Merck & Co. Business Overview
5.1.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Merck & Co. Neurological Disorder Drugs Products Introduction
5.2 GlaxoSmithKline plc
5.2.1 GlaxoSmithKline plc Company Profile
5.2.2 GlaxoSmithKline plc Business Overview
5.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 GlaxoSmithKline plc Neurological Disorder Drugs Products Introduction
5.3 Boehringer Ingelheim GmbH
5.3.1 Boehringer Ingelheim GmbH Company Profile
5.3.2 Boehringer Ingelheim GmbH Business Overview
5.3.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Boehringer Ingelheim GmbH Neurological Disorder Drugs Products Introduction
5.4 Novartis AG
5.4.1 Novartis AG Company Profile
5.4.2 Novartis AG Business Overview
5.4.3 Novartis AG Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Novartis AG Neurological Disorder Drugs Products Introduction
5.5 F. Hoffmann-La Roche Ltd.
5.5.1 F. Hoffmann-La Roche Ltd. Company Profile
5.5.2 F. Hoffmann-La Roche Ltd. Business Overview
5.5.3 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Products Introduction
5.6 AstraZeneca
5.6.1 AstraZeneca Company Profile
5.6.2 AstraZeneca Business Overview
5.6.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 AstraZeneca Neurological Disorder Drugs Products Introduction
5.7 Teva Pharmaceutical Industries Ltd.
5.7.1 Teva Pharmaceutical Industries Ltd. Company Profile
5.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
5.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Products Introduction
5.8 Bayer AG
5.8.1 Bayer AG Company Profile
5.8.2 Bayer AG Business Overview
5.8.3 Bayer AG Neurological Disorder Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Bayer AG Neurological Disorder Drugs Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Neurological Disorder Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Neurological Disorder Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Neurological Disorder Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Neurological Disorder Drugs Price by Types (2015-2020)
6.2 Global Neurological Disorder Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Neurological Disorder Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Neurological Disorder Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Neurological Disorder Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Neurological Disorder Drugs Sales, Price and Growth Rate of Antipsychotic
6.3.2 Global Neurological Disorder Drugs Sales, Price and Growth Rate of Hypnotic & Sedative
6.3.3 Global Neurological Disorder Drugs Sales, Price and Growth Rate of Analgesics
6.3.4 Global Neurological Disorder Drugs Sales, Price and Growth Rate of Anticoagulants
6.3.5 Global Neurological Disorder Drugs Sales, Price and Growth Rate of Others
6.4 Global Neurological Disorder Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Antipsychotic Market Revenue and Sales Forecast (2020-2025)
6.4.2 Hypnotic & Sedative Market Revenue and Sales Forecast (2020-2025)
6.4.3 Analgesics Market Revenue and Sales Forecast (2020-2025)
6.4.4 Anticoagulants Market Revenue and Sales Forecast (2020-2025)
6.4.5 Others Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Neurological Disorder Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Neurological Disorder Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Neurological Disorder Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Neurological Disorder Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Neurological Disorder Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Neurological Disorder Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Neurological Disorder Drugs Revenue, Sales and Growth Rate of Hospital (2015-2020)
7.3.2 Global Neurological Disorder Drugs Revenue, Sales and Growth Rate of Clinic (2015-2020)
7.3.3 Global Neurological Disorder Drugs Revenue, Sales and Growth Rate of Home (2015-2020)
7.4 Global Neurological Disorder Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospital Market Revenue and Sales Forecast (2020-2025)
7.4.2 Clinic Market Revenue and Sales Forecast (2020-2025)
7.4.3 Home Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Neurological Disorder Drugs Sales by Regions (2015-2020)
8.2 Global Neurological Disorder Drugs Market Revenue by Regions (2015-2020)
8.3 Global Neurological Disorder Drugs Market Forecast by Regions (2020-2025)
9 North America Neurological Disorder Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Neurological Disorder Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Neurological Disorder Drugs Market Analysis by Country
9.6.1 U.S. Neurological Disorder Drugs Sales and Growth Rate
9.6.2 Canada Neurological Disorder Drugs Sales and Growth Rate
9.6.3 Mexico Neurological Disorder Drugs Sales and Growth Rate
10 Europe Neurological Disorder Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Neurological Disorder Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Neurological Disorder Drugs Market Analysis by Country
10.6.1 Germany Neurological Disorder Drugs Sales and Growth Rate
10.6.2 United Kingdom Neurological Disorder Drugs Sales and Growth Rate
10.6.3 France Neurological Disorder Drugs Sales and Growth Rate
10.6.4 Italy Neurological Disorder Drugs Sales and Growth Rate
10.6.5 Spain Neurological Disorder Drugs Sales and Growth Rate
10.6.6 Russia Neurological Disorder Drugs Sales and Growth Rate
11 Asia-Pacific Neurological Disorder Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Neurological Disorder Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Neurological Disorder Drugs Market Analysis by Country
11.6.1 China Neurological Disorder Drugs Sales and Growth Rate
11.6.2 Japan Neurological Disorder Drugs Sales and Growth Rate
11.6.3 South Korea Neurological Disorder Drugs Sales and Growth Rate
11.6.4 Australia Neurological Disorder Drugs Sales and Growth Rate
11.6.5 India Neurological Disorder Drugs Sales and Growth Rate
12 South America Neurological Disorder Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Neurological Disorder Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Neurological Disorder Drugs Market Analysis by Country
12.6.1 Brazil Neurological Disorder Drugs Sales and Growth Rate
12.6.2 Argentina Neurological Disorder Drugs Sales and Growth Rate
12.6.3 Columbia Neurological Disorder Drugs Sales and Growth Rate
13 Middle East and Africa Neurological Disorder Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Neurological Disorder Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Neurological Disorder Drugs Market Analysis by Country
13.6.1 UAE Neurological Disorder Drugs Sales and Growth Rate
13.6.2 Egypt Neurological Disorder Drugs Sales and Growth Rate
13.6.3 South Africa Neurological Disorder Drugs Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Neurological Disorder Drugs Market Size and Growth Rate 2015-2025
Table Neurological Disorder Drugs Key Market Segments
Figure Global Neurological Disorder Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Neurological Disorder Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Neurological Disorder Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Merck & Co. Company Profile
Table Merck & Co. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline plc Company Profile
Table GlaxoSmithKline plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Market Revenue ($) Market Share 2015-2020
Table Boehringer Ingelheim GmbH Company Profile
Table Boehringer Ingelheim GmbH Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Market Revenue ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Market Revenue ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ltd. Company Profile
Table F. Hoffmann-La Roche Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffmann-La Roche Ltd. Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Market Revenue ($) Market Share 2015-2020
Table AstraZeneca Company Profile
Table AstraZeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Market Revenue ($) Market Share 2015-2020
Table Bayer AG Company Profile
Table Bayer AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Market Revenue ($) Market Share 2015-2020
Table Global Neurological Disorder Drugs Sales by Types (2015-2020)
Table Global Neurological Disorder Drugs Sales Share by Types (2015-2020)
Table Global Neurological Disorder Drugs Revenue ($) by Types (2015-2020)
Table Global Neurological Disorder Drugs Revenue Share by Types (2015-2020)
Table Global Neurological Disorder Drugs Price ($) by Types (2015-2020)
Table Global Neurological Disorder Drugs Market Forecast Sales by Types (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Antipsychotic Sales and Growth Rate (2015-2020)
Figure Global Antipsychotic Price (2015-2020)
Figure Global Hypnotic & Sedative Sales and Growth Rate (2015-2020)
Figure Global Hypnotic & Sedative Price (2015-2020)
Figure Global Analgesics Sales and Growth Rate (2015-2020)
Figure Global Analgesics Price (2015-2020)
Figure Global Anticoagulants Sales and Growth Rate (2015-2020)
Figure Global Anticoagulants Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Antipsychotic (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Antipsychotic (2020-2025)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Hypnotic & Sedative (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Hypnotic & Sedative (2020-2025)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Analgesics (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Analgesics (2020-2025)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Anticoagulants (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Anticoagulants (2020-2025)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Others (2020-2025)
Table Global Neurological Disorder Drugs Sales by Applications (2015-2020)
Table Global Neurological Disorder Drugs Sales Share by Applications (2015-2020)
Table Global Neurological Disorder Drugs Revenue ($) by Applications (2015-2020)
Table Global Neurological Disorder Drugs Revenue Share by Applications (2015-2020)
Table Global Neurological Disorder Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Hospital Sales and Growth Rate (2015-2020)
Figure Global Hospital Price (2015-2020)
Figure Global Clinic Sales and Growth Rate (2015-2020)
Figure Global Clinic Price (2015-2020)
Figure Global Home Sales and Growth Rate (2015-2020)
Figure Global Home Price (2015-2020)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Hospital (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Hospital (2020-2025)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Clinic (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Clinic (2020-2025)
Figure Global Neurological Disorder Drugs Market Revenue ($) and Growth Rate Forecast of Home (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast of Home (2020-2025)
Figure Global Neurological Disorder Drugs Sales and Growth Rate (2015-2020)
Table Global Neurological Disorder Drugs Sales by Regions (2015-2020)
Table Global Neurological Disorder Drugs Sales Market Share by Regions (2015-2020)
Figure Global Neurological Disorder Drugs Sales Market Share by Regions in 2019
Figure Global Neurological Disorder Drugs Revenue and Growth Rate (2015-2020)
Table Global Neurological Disorder Drugs Revenue by Regions (2015-2020)
Table Global Neurological Disorder Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Neurological Disorder Drugs Revenue Market Share by Regions in 2019
Table Global Neurological Disorder Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Neurological Disorder Drugs Market Forecast Sales (2020-2025)
Figure North America Neurological Disorder Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Neurological Disorder Drugs Market Forecast Sales (2020-2025)
Figure Europe Neurological Disorder Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure France Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Neurological Disorder Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Neurological Disorder Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure India Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Neurological Disorder Drugs Market Forecast Sales (2020-2025)
Figure South America Neurological Disorder Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Neurological Disorder Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Neurological Disorder Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Neurological Disorder Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Neurological Disorder Drugs Market Sales and Growth Rate (2015-2020)
Similar Reports
Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...
- Publish Date: July 31, 2017
- $5370
ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...
- Publish Date: March 1, 2016
- $3390
The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...
- Publish Date: January 15, 2016
- $2800
